RGD Reference Report - Expression of the bcl-6 and MUM1/IRF4 proteins correlate with overall and disease-specific survival in patients with primary cutaneous large B-cell lymphoma: a tissue microarray study. - Rat Genome Database

Send us a Message



Submit Data |  Help |  Video Tutorials |  News |  Publications |  Download |  REST API |  Citing RGD |  Contact   

Expression of the bcl-6 and MUM1/IRF4 proteins correlate with overall and disease-specific survival in patients with primary cutaneous large B-cell lymphoma: a tissue microarray study.

Authors: Sundram, U  Kim, Y  Mraz-Gernhard, S  Hoppe, R  Natkunam, Y  Kohler, S 
Citation: Sundram U, etal., J Cutan Pathol. 2005 Mar;32(3):227-34.
RGD ID: 11530023
Pubmed: PMID:15701085   (View Abstract at PubMed)
DOI: DOI:10.1111/j.0303-6987.2005.00298.x   (Journal Full-text)

BACKGROUND: Systemic B-cell lymphomas have been studied using microarrays, which has led to a better understanding of their molecular characteristics. Initial microarray studies of these lymphomas have implicated several genes as important predictors of outcome. In this study, we used a tissue microarray (TMA) to characterize primary cutaneous large B-cell lymphomas (PCLBCL). METHODS: We studied 14 patients for whom clinical follow up was available, including four patients whose lesions were limited to the leg on presentation. Immunohistochemical staining with CD20, CD44, CD21, CD5, CD10, bcl-2, bcl-6, Ki67, p53, and multiple myeloma 1 (MUM1) was examined. RESULTS: Our results identify two subgroups of lymphomas. The first group showed staining with bcl-6 and had an overall survival of 176 months (p = 0.003). The majority of this group was negative for MUM1. The second group lacked staining with bcl-6 and had an overall survival of 26 months, with a majority of these cases staining with MUM1. Three of four patients with PCLBCL of the leg showed no staining with bcl-6. CONCLUSIONS: Our study demonstrates the utility of TMAs in the analysis of PCLBCL and that expression of bcl-6 and MUM1 correlates with survival.



RGD Manual Disease Annotations    Click to see Annotation Detail View

  
Object SymbolSpeciesTermQualifierEvidenceWithNotesSourceOriginal Reference(s)
BCL6Humandiffuse large B-cell lymphoma disease_progressionIEP  RGD 
Bcl6Ratdiffuse large B-cell lymphoma disease_progressionISOBCL6 (Homo sapiens) RGD 
Bcl6Mousediffuse large B-cell lymphoma disease_progressionISOBCL6 (Homo sapiens) RGD 
IRF4Humandiffuse large B-cell lymphoma disease_progressionIEP  RGD 
Irf4Ratdiffuse large B-cell lymphoma disease_progressionISOIRF4 (Homo sapiens) RGD 
Irf4Mousediffuse large B-cell lymphoma disease_progressionISOIRF4 (Homo sapiens) RGD 

Objects Annotated

Genes (Rattus norvegicus)
Bcl6  (BCL6, transcription repressor)
Irf4  (interferon regulatory factor 4)

Genes (Mus musculus)
Bcl6  (B cell leukemia/lymphoma 6)
Irf4  (interferon regulatory factor 4)

Genes (Homo sapiens)
BCL6  (BCL6 transcription repressor)
IRF4  (interferon regulatory factor 4)


Additional Information